Niemann-pick type C2 deficiency in human fibroblasts confers robust and selective activation of prostaglandin E2 biosynthesis

Andrey Frolov, Hua Dong, Min Jiang, Lihua Yang, Erik C. Cook, Rahul Matnani, Bruce D. Hammock, Leslie J. Crofford

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: NPC2 is a protein that negatively regulates fibroblast activation. Results: NPC2-null human fibroblasts display induction of cPLA2, COX-2, and mPGES-1 expression that may contribute to the observed robust and selective activation of PGE2 biosynthesis. Conclusion: NPC2 may regulate the activated fibroblast inflammatory program through modulation of a cPLA2-dependent biosynthetic pathway. Significance: NPC2 may represent a novel therapeutic tool for the treatment of inflammatory diseases.

Original languageEnglish (US)
Pages (from-to)23696-23703
Number of pages8
JournalJournal of Biological Chemistry
Volume288
Issue number33
DOIs
StatePublished - Aug 16 2013

Fingerprint

Biosynthesis
Fibroblasts
Dinoprostone
Chemical activation
Biosynthetic Pathways
Modulation
Proteins
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Niemann-pick type C2 deficiency in human fibroblasts confers robust and selective activation of prostaglandin E2 biosynthesis. / Frolov, Andrey; Dong, Hua; Jiang, Min; Yang, Lihua; Cook, Erik C.; Matnani, Rahul; Hammock, Bruce D.; Crofford, Leslie J.

In: Journal of Biological Chemistry, Vol. 288, No. 33, 16.08.2013, p. 23696-23703.

Research output: Contribution to journalArticle

Frolov, A, Dong, H, Jiang, M, Yang, L, Cook, EC, Matnani, R, Hammock, BD & Crofford, LJ 2013, 'Niemann-pick type C2 deficiency in human fibroblasts confers robust and selective activation of prostaglandin E2 biosynthesis', Journal of Biological Chemistry, vol. 288, no. 33, pp. 23696-23703. https://doi.org/10.1074/jbc.M112.445916
Frolov, Andrey ; Dong, Hua ; Jiang, Min ; Yang, Lihua ; Cook, Erik C. ; Matnani, Rahul ; Hammock, Bruce D. ; Crofford, Leslie J. / Niemann-pick type C2 deficiency in human fibroblasts confers robust and selective activation of prostaglandin E2 biosynthesis. In: Journal of Biological Chemistry. 2013 ; Vol. 288, No. 33. pp. 23696-23703.
@article{bb71772fe2424f09af5e33e1c76d0aff,
title = "Niemann-pick type C2 deficiency in human fibroblasts confers robust and selective activation of prostaglandin E2 biosynthesis",
abstract = "Background: NPC2 is a protein that negatively regulates fibroblast activation. Results: NPC2-null human fibroblasts display induction of cPLA2, COX-2, and mPGES-1 expression that may contribute to the observed robust and selective activation of PGE2 biosynthesis. Conclusion: NPC2 may regulate the activated fibroblast inflammatory program through modulation of a cPLA2-dependent biosynthetic pathway. Significance: NPC2 may represent a novel therapeutic tool for the treatment of inflammatory diseases.",
author = "Andrey Frolov and Hua Dong and Min Jiang and Lihua Yang and Cook, {Erik C.} and Rahul Matnani and Hammock, {Bruce D.} and Crofford, {Leslie J.}",
year = "2013",
month = "8",
day = "16",
doi = "10.1074/jbc.M112.445916",
language = "English (US)",
volume = "288",
pages = "23696--23703",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "33",

}

TY - JOUR

T1 - Niemann-pick type C2 deficiency in human fibroblasts confers robust and selective activation of prostaglandin E2 biosynthesis

AU - Frolov, Andrey

AU - Dong, Hua

AU - Jiang, Min

AU - Yang, Lihua

AU - Cook, Erik C.

AU - Matnani, Rahul

AU - Hammock, Bruce D.

AU - Crofford, Leslie J.

PY - 2013/8/16

Y1 - 2013/8/16

N2 - Background: NPC2 is a protein that negatively regulates fibroblast activation. Results: NPC2-null human fibroblasts display induction of cPLA2, COX-2, and mPGES-1 expression that may contribute to the observed robust and selective activation of PGE2 biosynthesis. Conclusion: NPC2 may regulate the activated fibroblast inflammatory program through modulation of a cPLA2-dependent biosynthetic pathway. Significance: NPC2 may represent a novel therapeutic tool for the treatment of inflammatory diseases.

AB - Background: NPC2 is a protein that negatively regulates fibroblast activation. Results: NPC2-null human fibroblasts display induction of cPLA2, COX-2, and mPGES-1 expression that may contribute to the observed robust and selective activation of PGE2 biosynthesis. Conclusion: NPC2 may regulate the activated fibroblast inflammatory program through modulation of a cPLA2-dependent biosynthetic pathway. Significance: NPC2 may represent a novel therapeutic tool for the treatment of inflammatory diseases.

UR - http://www.scopus.com/inward/record.url?scp=84882295810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882295810&partnerID=8YFLogxK

U2 - 10.1074/jbc.M112.445916

DO - 10.1074/jbc.M112.445916

M3 - Article

VL - 288

SP - 23696

EP - 23703

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 33

ER -